盲穿与超声引导下皮质类固醇注射治疗莫顿神经瘤的长期比较
这项评估者盲法随机试验比较了盲穿与超声引导下注射治疗莫顿神经瘤的疗效,随访长达3年。盲穿组33例由骨科医生按解剖标志注射,超声引导组38例由肌骨放射科医生在超声引导下注射。结果显示超声引导组在疼痛和足部功能改善上均优于盲穿组,3年满意度更高(87%对59.1%)。
要点
- 超声引导下皮质类固醇注射治疗莫顿神经瘤可使超过75%的患者获得长期疼痛缓解。
- 超声引导组在随访3年内疼痛改善优于盲穿组,45天至2年期间足部功能障碍改善也优于盲穿组。
- 同侧存在神经瘤与更差的长期功能障碍评分相关。
核心结论
- 超声引导下注射治疗莫顿神经瘤在长期改善比例上优于盲穿注射。
研究设计与样本
- 评估者盲法随机试验;盲穿组33例由经验丰富的骨科医生根据解剖标志注射,超声引导组38例由经验丰富的肌骨放射科医生在超声引导下注射。
临床应用与阅片要点
- 注射方案为每个含莫顿神经瘤的跖骨间隙注射1 ml 2%甲哌卡因和40 mg曲安奈德。
- 随访前3个月内最多允许注射4次。
- 随访通过电话和/或预约面诊在15天、1个月、45天、2个月、3个月、6个月及1、2、3年时进行。
- 评估采用视觉模拟评分和曼彻斯特足痛与功能障碍指数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This work compares the effectiveness of blind versus ultrasound (US)-guided injections for Morton neuroma (MN) up to 3 years of follow-up.
METHODS: This is an evaluator-blinded randomised trial in which 33 patients with MN were injected by an experienced orthopaedic surgeon based on anatomical landmarks (blind injection, group 1) and 38 patients were injected by an experienced musculoskeletal radiologist under US guidance (group 2). Patients were assessed using the visual analogue scale and the Manchester Foot Pain and Disability index (MFPDI). Injections consisted of 1 ml of 2% mepivacaine and 40 mg triamcinolone acetonide in each web space with MN. Up to 4 injections were allowed during the first 3 months of follow-up. Follow-up was performed by phone calls and/or scheduled consultations at 15 days, 1 month, 45 days, 2 months, 3 months, 6 months and 1, 2 and 3 years. Statistical analysis was performed using unpaired Student's t tests.
RESULTS: No differences in age or clinical measures were found at presentation between group 1 (VAS, 8.5 ± 0.2; MFPDI, 40.9 ± 1.1) and group 2 (VAS, 8.4 ± 0.2; MFPDI, 39.8 ± 1.2). Improvement in VAS was superior in group 2 up to 3 years of follow-up (p < 0.05). Improvement in MFPDI was superior in group 2 from 45 days to 2 years of follow-up (p < 0.05). Satisfaction with the treatment was higher in group 2 (87%) versus group 1 (59.1%) at 3 years of follow-up.
CONCLUSION: Ultrasound-guided injections lead to a greater percentage of long-term improvement than blind injections in MN.
KEY POINTS: • Ultrasound-guided corticosteroid injections in Morton neuroma provide long-term pain relief in more than 75% of patients. • Ultrasound-guided injections in Morton neuroma led to greater long-term pain relief and less disability than blind injections up to 3 years of follow-up. • The presence of an ipsilateral neuroma is associated with worse long-term disability score.
引用
- Santiago, Muñoz, Ramos-Bossini, et al. Long-term comparison between blind and ultrasound-guided corticoid injections in Morton neuroma. Eur Radiol. 2022. PMID: 35726101. doi:10.1007/s00330-022-08932-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。